Conferences: ESMO I-O 2023

Lifileucel TILs: 4-Year Melanoma Efficacy Follow-up

Posted by Oncweekly Editor | Jan 3, 2024 | Melanoma, Skin Cancer |

KEY TAKEAWAYS The C-144-01 phase II trial aimed to present 4-year follow-up data from study...

Read More

Safety of INCB099280 In Advanced Solid Tumors

Posted by Oncweekly Editor | Jan 3, 2024 | Other Cancers |

KEY TAKEAWAYS An interventional phase I trial aimed to analyze the expanded safety and efficacy...

Read More

Safety of PD-L1 Inhibitor INCB099318 in Advanced Solid Tumors

Posted by Oncweekly Editor | Jan 3, 2024 | Other Cancers |

KEY TAKEAWAYS The phase I trial aimed to present updated efficacy and safety results of the oral...

Read More